A rare examination of an Alzheimer’s patient’s brain reveals that regions where amyloid plaques were cleared showed significantly less tau damage than areas where plaques remained.
Scientists have identified the P2X7 receptor as a key driver of brain inflammation. Blocking this target significantly reduced inflammatory responses in human tissue samples.